Net Income (Loss) Per Share

9 Months Ended

Sep. 30, 2021

NET INCOME (LOSS) PER SHARE

Basic net income (loss) per share is computed by dividing net income (loss) available to common stockholders by the weighted average number of the Company’s common stock outstanding during the period. Diluted net income (loss) per share reflects the potential dilution that would occur if securities or other contracts to issue common stock were exercised or converted into common stock.

For the three and nine months ended September 30, 2021, there were 1,513,288 and 1,489,158 common stock equivalents, respectively, related to equity-based awards were not included in the diluted earnings per share calculation as the shares would be antidilutive. Similarly, 182,803 and 1,722,014 common stock equivalents were excluded in the diluted earnings per share calculation for the three and nine months ended September 30, 2020, respectively.


	Three months ended September 30,				Nine months ended September 30,
In thousands except per share amounts	2021		2020		2021		2020



Net income (loss) available to common stockholders	$	(54,768)	$	26,856	$	(20,562)	$	13,747

Weighted average shares:
Basic	254,744		240,983		247,675		240,729
Effect of stock-based compensation plans	—		2,866		—		1,277
Diluted	254,744		243,849		247,675		242,006

Income (loss) per share:


Basic	$	(0.21)	$	0.11	$	(0.08)	$	0.06




Diluted(1)	$	(0.21)	$	0.11	$	(0.08)	$	0.06

On April 23, 2020, the Company entered into an ATM Equity Offering Sales Agreement (the “Sales Agreement”) with BofA Securities, Inc. and RBC Capital Markets, LLC as sales agents (the “Sales Agents”) and filed a prospectus supplement for the sale of its common stock, par value $0.01 per share, by way of an “at the market” offering having an aggregate offering price of up to $100,000,000 (the “ATM Program”). Sales under the ATM Program, if any, will be made pursuant to the terms of the Sales Agreement. At September 30, 2021, the Company had not elected to sell any shares of its common stock under the ATM Program.